SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?


To: FTJoe who wrote (571)4/7/1998 7:47:00 PM
From: yosi s  Respond to of 1491
 
Tamoxiphene made the news which is nice,
but currently it is immaterial for pars.
PARS may go forward sooner, with its tamoxipene analogue.
At present what is important is BOL sales of Alrex and Lotemax.
Than awaiting results of phase 2 HU211.
And plans to go into phase 3 for HU211 which include partner etc.